PTC
IONS icon

Private Trust Company’s Ionis Pharmaceuticals IONS Stock Holding History

Private Trust Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11
Closed -$870 – 2653
2025
Q4 		$870 Buy
+11
New +$828 ﹤0.01% 2438
2025
Q1 		– Sell
-48
Closed -$1.68K – 2516
2024
Q4 		$1.68K Hold
48
– – ﹤0.01% 2189
2024
Q3 		$1.92K Sell
48
-35
-42% -$1.63K ﹤0.01% 2156
2024
Q2 		$3.96K Sell
83
-295
-78% -$12.1K ﹤0.01% 2008
2024
Q1 		$16.4K Buy
378
+11
+3% +$524 ﹤0.01% 1506
2023
Q4 		$18.6K Buy
367
+257
+234% +$12.3K ﹤0.01% 1431
2023
Q3 		$4.99K Hold
110
– – ﹤0.01% 1877
2023
Q2 		$4.51K Buy
110
+107
+3,567% +$4.11K ﹤0.01% 1908
2023
Q1 		$107 Sell
3
-36
-92% -$1.35K ﹤0.01% 2257
2022
Q4 		$1K Hold
39
– – ﹤0.01% 2100
2022
Q3 		$2K Hold
39
– – ﹤0.01% 1882
2022
Q2 		$1K Buy
+39
New +$1.47K ﹤0.01% 2040
2014
Q4 		– Sell
-391
Closed -$15K – 723
2014
Q3 		$15K Buy
391
+46
+13% +$1.63K 0.01% 941
2014
Q2 		$12K Sell
345
-43
-11% -$1.35K ﹤0.01% 1014
2014
Q1 		$17K Buy
388
+6
+2% +$291 0.01% 783
2013
Q4 		$15K Buy
382
+12
+3% +$428 0.01% 800
2013
Q3 		$14K Buy
370
+25
+7% +$747 0.01% 779
2013
Q2 		$9K Buy
+345
New +$7.34K ﹤0.01% 884

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Private Trust Company's IONS Position: Q1 2026 in Review

Private Trust Company sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 11 shares — an estimated $870 sold.

Private Trust Company first reported a position in IONS in Q2 2013 and held it in 18 quarters. The position peaked at $18.6K in Q4 2023. 496 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Private Trust Company reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Private Trust Company sold 11 Ionis Pharmaceuticals shares in Q1 2026, an estimated $870.
  • Private Trust Company first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Private Trust Company's Ionis Pharmaceuticals position peaked at $18.6K in Q4 2023.
  • 496 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.